Page last updated: 2024-10-24

carmustine and Heart Disease, Ischemic

carmustine has been researched along with Heart Disease, Ischemic in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research Excerpts

ExcerptRelevanceReference
"We describe a case of acute myocardial ischemia following carmustine treatment during the BEAM regimen."3.71Acute myocardial ischemia after high-dose therapy with BEAM regimen. ( Gallet, B; Genet, P; Jondeau, K; Laribi, K; Lionnet, F; Pulik, M; Touahri, T, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genet, P1
Pulik, M1
Gallet, B1
Lionnet, F1
Jondeau, K1
Touahri, T1
Laribi, K1

Other Studies

1 other study available for carmustine and Heart Disease, Ischemic

ArticleYear
Acute myocardial ischemia after high-dose therapy with BEAM regimen.
    Bone marrow transplantation, 2002, Volume: 30, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etopo

2002